Therefore, to explore the efficacy and safety of anti-EGFR in combination with standard therapy for nasopharyngeal cancer patients, a comprehensive search and meta-analysis of randomised controlled trials were conducted in this study with the aim of rereporting relevant data for future therapy recommendations and clinical trials. This evidence concerns the gene EGFR and nasopharyngeal carcinoma.